HLB Therapeutics (115450.KQ) Earnings Analysis
HLB Therapeutics (115450.KQ) has no confirmed upcoming earnings date. Trailing P/E -20.63.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 115450.KQ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 115450.KQ. This page updates as the calendar is published.
115450.KQ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-16 | 28.85 KRW | n/a | n/a | n/a |
| 2025-11-12 | -65 KRW | n/a | n/a | n/a |
| 2025-08-18 | 1 KRW | n/a | n/a | n/a |
| 2025-03-17 | 22.43 KRW | n/a | n/a | n/a |
| 2024-11-14 | -32.39997 KRW | n/a | n/a | n/a |
| 2024-08-14 | -299.00678 KRW | n/a | n/a | n/a |
115450.KQ valuation and analyst view
| Trailing P/E | -20.63 |
|---|---|
| Trailing EPS | -82.96872 KRW |
| Price / book | 1.01 |
| Dividend yield | 0.00% |
| Market cap | 147.48B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is HLB Therapeutics (115450.KQ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 115450.KQ. This page updates as the calendar is published.
Did 115450.KQ beat earnings last quarter?
Consensus estimate data was not available for 115450.KQ's 2026-03-16 report.
What is 115450.KQ's current P/E ratio and EPS?
115450.KQ trades at a trailing P/E of -20.63 on trailing EPS of -82.96871673262054 KRW.
What do analysts rate 115450.KQ?
115450.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.